10-Q/A

BIOTIME, INC 10-QA 9-30-2014

Company: Lineage Cell Therapeutics, Inc.
Filed: January 13, 2015
Period of Report: September 30, 2014
Accession Number: 0001140361-15-001603

View Document ↗ View on SEC.gov ↗